7 Result: Accenture
Ahead of Earnings: Cintas, Accenture, and Darden Restaurants in the Spotlight
December 14th, 2025
Las Vegas, NV / CRWE PRESS RELEASE / December 14, 2025 - Several companies are scheduled to release their financial results on Thursday, December 18, including: Cintas Corporation (Nasdaq: CTAS), a provider of corporate identity uniforms and facil. Read more
Wall Street Eyes Accenture, TD SYNNEX, Concentrix Ahead of Earnings
September 22nd, 2025
LAS VEGAS, NV / CRWE PRESS RELEASE / September 22, 2025 - Several notable companies are set to release their financial results on Thursday, September 25, including: Accenture plc (NYSE: ACN), a global consulting and IT services leader, will announ. Read more
Earnings Countdown: Accenture, NIKE, and Micron Technology Brace for Reports
March 16th, 2025
Several high-profile companies are set to announce their latest financial results on Thursday, March 20, including: Accenture plc (NYSE: ACN), a global consulting and IT services firm, will report its second-quarter fiscal 2025 earnings before the. Read more
Eyes on the Numbers: Accenture, FedEx, and FactSet's Earnings Preview
December 16th, 2023
On Tuesday, December 19, several prominent companies are scheduled to unveil their financial performance, including: Accenture plc (NYSE: ACN), a global professional services firm, is set to release its first-quarter fiscal 2024 financial results . Read more
Setback for BrainStorm Cell Therapeutics; Accenture Posts Mixed Results
September 28th, 2023
BrainStorm Cell Therapeutics Inc. (Nasdaq: BCLI), a biotechnology company that specializes in developing innovative stem cell therapies for neurodegenerative diseases, faced a setback as the U.S. Food and Drug Administration's Cellular, Tissue, and G. Read more
Earnings Spotlight: Accenture, NIKE, and Jabil on the Horizon
September 24th, 2023
On Thursday, September 28, a number of companies are scheduled to announce their financial results, including: Accenture plc (NYSE: ACN), a global consulting and professional services firm, is set to announce its fourth-quarter and full-year fisca. Read more
Evaxion Biotech: Promising EVX-01 Clinical Data; Celsius, Accenture, Five Below: PT Raised
June 04th, 2023
Evaxion Biotech A/S (Nasdaq: EVAX) announced encouraging findings from its EVX-01 Phase 1 clinical trial, which assessed the safety and effectiveness of EVX-01 in combination with a checkpoint inhibitor for metastatic melanoma patients. Acco. Read more
Want To Find Some News?
News By Industries
Recent Post
-
March 19th, 2026
How High School Graduates Can Kickstart Their Football Career
March 18th, 2026March 18th, 2026




Member Login